Elevance Health (ELV) and Molina Healthcare (MOH) represent two prominent players in the U.S. managed healthcare sector, making their stock comparison relevant for investors seeking exposure to government-sponsored insurance programs and broader healthcare services. Traders and portfolio managers focused on healthcare equities often evaluate these names together due to overlapping exposure to Medicaid and Medicare dynamics, regulatory shifts, and medical cost trends. This analysis examines their business models, recent performance drivers, and relative positioning to support informed decision-making in the prevailing market environment.
Elevance Health, Inc. provides a range of health insurance products and services, including commercial plans, Medicare Advantage, and Medicaid managed care across multiple states. The company’s scale supports diversified revenue and operational efficiencies in claims processing and network management. In recent weeks, ELV stock has reflected steady investor interest ahead of its second-quarter 2026 earnings call scheduled for July 15, with analyst firms raising price targets amid expectations for adjusted earnings growth. Performance has been influenced by ongoing efforts to manage medical loss ratios and integrate technology platforms such as Health OS for clinical reviews. Broader market activity shows resilience despite sector headwinds, with sentiment supported by the company’s established market position and guidance updates.
Molina Healthcare, Inc. specializes in managed care services primarily for Medicaid, Medicare, and marketplace enrollees, targeting lower-income and underserved populations. Its business model emphasizes cost-effective care delivery in government programs. Recent market activity has featured positive momentum following the company’s win of an Illinois Medicaid contract in early June 2026, alongside continued emphasis on operational execution and margin recovery. MOH stock has responded to these developments with notable year-to-date gains, though it remains sensitive to membership changes and medical cost pressures. Upcoming second-quarter earnings, set for release around July 23, 2026, are anticipated to provide further clarity on these trends, shaping near-term sentiment in a challenging reimbursement landscape.
Tickeron’s Trending AI Robots page curates a selection of high-performing AI trading bots from hundreds available on the platform. These bots trade thousands of different tickers across equities, options, and other instruments, yet only those demonstrating superior adaptability to prevailing market conditions earn placement in this curated section. Available bots span diverse trading styles, strategies, timeframes, and performance statistics, with metrics such as win rates, profit factors, and drawdown profiles varying widely to suit different risk tolerances. Investors can explore detailed backtested results and real-time signals for bots focused on healthcare names and broader sectors. Review the full selection on the Trending AI Robots page to identify strategies aligned with current conditions.
Elevance Health (ELV) and Molina Healthcare (MOH) both operate within the managed healthcare industry but differ in scale and focus. ELV maintains a larger national footprint with greater exposure to commercial insurance, providing relative stability through revenue diversification. In contrast, MOH concentrates on Medicaid and similar government programs, offering higher growth potential from membership expansion but increased vulnerability to policy and funding changes. Recent momentum favors MOH on contract successes, while ELV shows steadier analyst support ahead of earnings. Risk factors include medical cost inflation for both, though ELV’s size may buffer volatility compared with MOH’s narrower profile. Sector sentiment remains tied to reimbursement rates and utilization trends, creating trade-offs between defensive positioning at ELV and opportunistic exposure at MOH.
Based on observable factors such as trend consistency in recent market activity, contract catalysts, and relative stability metrics, Tickeron’s AI models currently assign a modestly higher probabilistic preference to MOH over ELV in the near term. This positioning reflects MOH’s demonstrated momentum from recent Medicaid contract developments and operational focus, which align with patterns favoring adaptive strategies in the current healthcare environment. However, ELV’s larger scale and diversified model provide a counterbalancing element of resilience that could support outperformance under different conditions. The assessment remains probabilistic and subject to evolving data inputs.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ELV’s FA Score shows that 3 FA rating(s) are green whileMOH’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ELV’s TA Score shows that 4 TA indicator(s) are bullish while MOH’s TA Score has 4 bullish TA indicator(s).
ELV (@Managed Health Care) experienced а +4.16% price change this week, while MOH (@Managed Health Care) price change was +6.67% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +0.83%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was +35.30%.
ELV is expected to report earnings on Jul 15, 2026.
MOH is expected to report earnings on Jul 22, 2026.
Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| ELV | MOH | ELV / MOH | |
| Capitalization | 92.3B | 12.7B | 727% |
| EBITDA | N/A | 617M | - |
| Gain YTD | 22.531 | 39.956 | 56% |
| P/E Ratio | 18.02 | 65.12 | 28% |
| Revenue | 200B | 45.1B | 443% |
| Total Cash | N/A | 9.25B | - |
| Total Debt | 31.8B | 3.95B | 806% |
ELV | MOH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 7 Undervalued | 80 Overvalued | |
PROFIT vs RISK RATING 1..100 | 84 | 100 | |
SMR RATING 1..100 | 98 | 87 | |
PRICE GROWTH RATING 1..100 | 18 | 6 | |
P/E GROWTH RATING 1..100 | 26 | 2 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ELV's Valuation (7) in the Managed Health Care industry is significantly better than the same rating for MOH (80). This means that ELV’s stock grew significantly faster than MOH’s over the last 12 months.
ELV's Profit vs Risk Rating (84) in the Managed Health Care industry is in the same range as MOH (100). This means that ELV’s stock grew similarly to MOH’s over the last 12 months.
MOH's SMR Rating (87) in the Managed Health Care industry is in the same range as ELV (98). This means that MOH’s stock grew similarly to ELV’s over the last 12 months.
MOH's Price Growth Rating (6) in the Managed Health Care industry is in the same range as ELV (18). This means that MOH’s stock grew similarly to ELV’s over the last 12 months.
MOH's P/E Growth Rating (2) in the Managed Health Care industry is in the same range as ELV (26). This means that MOH’s stock grew similarly to ELV’s over the last 12 months.
| ELV | MOH | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 67% | 4 days ago 58% |
| Stochastic ODDS (%) | 4 days ago 53% | 4 days ago 75% |
| Momentum ODDS (%) | 4 days ago 65% | 4 days ago 58% |
| MACD ODDS (%) | 4 days ago 65% | 4 days ago 69% |
| TrendWeek ODDS (%) | 4 days ago 58% | 4 days ago 73% |
| TrendMonth ODDS (%) | 4 days ago 56% | 4 days ago 72% |
| Advances ODDS (%) | 12 days ago 56% | 4 days ago 67% |
| Declines ODDS (%) | 14 days ago 56% | 8 days ago 64% |
| BollingerBands ODDS (%) | 4 days ago 64% | 4 days ago 73% |
| Aroon ODDS (%) | 4 days ago 56% | 4 days ago 66% |
A.I.dvisor indicates that over the last year, ELV has been loosely correlated with UNH. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ELV jumps, then UNH could also see price increases.